The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL. (Q38299311)

1 September 2017

The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL. (English)

1 reference

1 September 2017

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936528%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

E Vasyutina

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936528%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

J M Boucas

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936528%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

J Bloehdorn

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936528%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

C Aszyk

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936528%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

G Crispatzu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936528%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

M Stiefelhagen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936528%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

A Breuer

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936528%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

P Mayer

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936528%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

H Döhner

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936528%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

D Beutner

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936528%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

A Rosenwald

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936528%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

S Stilgenbauer

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936528%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

M Hallek

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936528%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

A Benner

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936528%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

M Herling

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936528%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

publication date

4 May 2015

1 reference

1 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936528%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936528%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

2003-2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936528%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936528%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2015.114

10 June 2020

exact match

0 references

cites work

Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

High TCL1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

Tcl1 enhances Akt kinase activity and mediates its nuclear translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

The protooncogene TCL1 is an Akt kinase coactivator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

Tcl1 functions as a transcriptional regulator and is directly involved in the pathogenesis of CLL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

Tcl1 interacts with Atm and enhances NF-κB activation in hematologic malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

miR-34b/miR-34c: a regulator of TCL1 expression in 11q- chronic lymphocytic leukaemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

The impact of microRNAs on protein output

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

Differential microRNA profiles and their functional implications in different immunogenetic subsets of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

MicroRNAs and B cell receptor signaling in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

EVI-1 modulates leukemogenic potential and apoptosis sensitivity in human acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

CD44 regulates the apoptotic response and promotes disease development in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

Laminin-332 (Laminin-5) is the major motility ligand for B cell chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

Adenosine receptors: therapeutic aspects for inflammatory and immune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

Pathogenetic significance of ecotropic viral integration site-1 in hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

EVI1 and hematopoietic disorders: history and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

Molecular characterization of neoplastic and normal "sister" lymphoblastoid B-cell lines from chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

TCL1 in B-cell tumors retains its normal b-cell pattern of regulation and is a marker of differentiation stage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

Cellular origin and pathophysiology of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

CD5+CD23+ leukemic cell populations in TCL1 transgenic mice show significantly increased proliferation and Akt phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

TORC2 regulates germinal center repression of the TCL1 oncoprotein to promote B cell development and inhibit transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

The role of EVI1 in normal and leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

Evi1 is essential for hematopoietic stem cell self-renewal, and its expression marks hematopoietic cells with long-term multilineage repopulating activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

CML cells expressing the TEL/MDS1/EVI1 fusion are resistant to imatinib-induced apoptosis through inhibition of BAD, but are resensitized with ABT-737.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

Generalized maximally selected statistics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.114

MicroRNA expression in chronic lymphocytic leukemia developing autoimmune hemolytic anemia

21 January 2018

1 reference

12 December 2020

TCL1 shows a regulated expression pattern in chronic lymphocytic leukemia that correlates with molecular subtypes and proliferative state

1 reference

12 December 2020

Fluorescent-labeled DNA probes applied to novel biological aspects of B-cell chronic lymphocytic leukemia

1 reference

12 December 2020

Functional dissection of the chromosome 13q14 tumor-suppressor locus using transgenic mouse lines

1 reference

12 December 2020

Stromal cells modulate TCL1 expression, interacting AP-1 components and TCL1-targeting micro-RNAs in chronic lymphocytic leukemia

1 reference

12 December 2020